NeoChord TACT Post-Market Surveillance Registry

NeoChord

Status: Completed

Conditions: Heart Valve Diseases; Mitral Valve Insufficiency; Cardiovascular Diseases; Heart Diseases

Study type: Observational

Funder types: Industry

Identifiers

NCT01784055

800001-001

Details and patient eligibility

About

To monitor the long-term performance of the CE Marked NeoChord Artificial Chordae Delivery System

Enrollment: 126 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Grade 3+ or 4+ mitral valve regurgitation

Exclusion criteria

• Heavily calcified valves
• Valvular retraction with severely reduced mobility
• Active bacterial endocarditis
• Complex mechanism of MR (leaflet perforation, etc.)
• Significant tethering of leaflets
• Inflammatory valve disease